Healthcare provider Centene (NYSE: CNC) provides programs and services to under-insured and uninsured individuals in the United States. The company is set to release third quarter earnings results on October 22, but the stock ran in to some resistance ahead of the report.
The daily chart shows that the stock has been trending lower over the last five months with a trend channel forming that defines the various cycles within the trend. The stock hit the upper rail of the channel on October 19 and then turned lower on October 21. The chart also shows that the stochastic readings were in overbought territory and made a bearish crossover on the 21st.
If we look at the weekly chart it shows that the downward trend extends all the way back to August 2018. It also shows a longer term trend channel that connects the highs over the past year.
The stock just moved out of oversold territory on the weekly chart, but there is potential resistance just overhead at the 13-week moving average.
In addition to the bearish signal from the daily stochastic crossover, the Tickeron Trend Prediction engine generated a bearish signal for Centene on October 18. The prediction showed a confidence level of 89% and calls for a decline of at least 4% within the next month. Past predictions for the stock have been accurate 77% of the time.
Looking at the fundamentals for the company, Tickeron’s ratings show three separate measures where Centene ranks below average. The Tickeron Price Growth Rating for Centene is 67, indicating slightly worse than average price growth. CNC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for Centene is 79, pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents. A rating of 1 indicates highest PE growth while a rating of 100 indicates lowest PE growth.
The Tickeron Valuation Rating of 81 indicates that the company is slightly overvalued in the industry. A rating of 1 points to the most undervalued stocks, while a rating of 100 points to the most overvalued stocks. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization.
Analysts expect Centene to report earnings of $0.95 for the third quarter on revenue of $18.43 billion. In the third quarter of 2018 the company earned $0.89 on revenue of $16.18 billion. This means earnings are expected to grow by 6.7% and revenue is expected to grow by 13.9%. Those growth rates are far below the rates from last quarter and the last three years.
The sentiment toward Centene is mixed ahead of the earnings report. There are 17 analysts following the stock at this time with 15 “buy” ratings and two “hold” ratings. This puts the buy percentage at 88.2% and that is far more bullish than the average stock. On the other hand, the short interest ratio is at 7.1 and that indicates far more bearish sentiment than the average stock.